Randomized, phase III study of weekly paclitaxel in combination with carboplatin versus standard every-3-weeks administration of carboplatin and paclitaxel for patients with previously untreated advanced non-small-cell lung cancer - Belani, C P; Ramalingam, S; Perry, M C (J Clin Oncol, 2008)